1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gout Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 NSAIDs 1.2.3 Corticosteroids 1.2.4 Colchicine 1.2.5 Urate-Lowering Agents 1.3 Market by Application 1.3.1 Global Gout Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Acute Gout 1.3.3 Chronic Gout 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gout Therapeutics Market Perspective (2016-2027) 2.2 Gout Therapeutics Growth Trends by Regions 2.2.1 Gout Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gout Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Gout Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Gout Therapeutics Industry Dynamic 2.3.1 Gout Therapeutics Market Trends 2.3.2 Gout Therapeutics Market Drivers 2.3.3 Gout Therapeutics Market Challenges 2.3.4 Gout Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gout Therapeutics Players by Revenue 3.1.1 Global Top Gout Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gout Therapeutics Revenue 3.4 Global Gout Therapeutics Market Concentration Ratio 3.4.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2020 3.5 Gout Therapeutics Key Players Head office and Area Served 3.6 Key Players Gout Therapeutics Product Solution and Service 3.7 Date of Enter into Gout Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gout Therapeutics Breakdown Data by Type 4.1 Global Gout Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Gout Therapeutics Forecasted Market Size by Type (2022-2027) 5 Gout Therapeutics Breakdown Data by Application 5.1 Global Gout Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Gout Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gout Therapeutics Market Size (2016-2027) 6.2 North America Gout Therapeutics Market Size by Type 6.2.1 North America Gout Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Gout Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Gout Therapeutics Market Size by Type (2016-2027) 6.3 North America Gout Therapeutics Market Size by Application 6.3.1 North America Gout Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Gout Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Gout Therapeutics Market Size by Application (2016-2027) 6.4 North America Gout Therapeutics Market Size by Country 6.4.1 North America Gout Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Gout Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Gout Therapeutics Market Size (2016-2027) 7.2 Europe Gout Therapeutics Market Size by Type 7.2.1 Europe Gout Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Gout Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Gout Therapeutics Market Size by Type (2016-2027) 7.3 Europe Gout Therapeutics Market Size by Application 7.3.1 Europe Gout Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Gout Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Gout Therapeutics Market Size by Application (2016-2027) 7.4 Europe Gout Therapeutics Market Size by Country 7.4.1 Europe Gout Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Gout Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gout Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Gout Therapeutics Market Size by Type 8.2.1 Asia-Pacific Gout Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gout Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gout Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Gout Therapeutics Market Size by Application 8.3.1 Asia-Pacific Gout Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gout Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gout Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Gout Therapeutics Market Size by Region 8.4.1 Asia-Pacific Gout Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gout Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gout Therapeutics Market Size (2016-2027) 9.2 Latin America Gout Therapeutics Market Size by Type 9.2.1 Latin America Gout Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Gout Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Gout Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Gout Therapeutics Market Size by Application 9.3.1 Latin America Gout Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Gout Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Gout Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Gout Therapeutics Market Size by Country 9.4.1 Latin America Gout Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Gout Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gout Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Gout Therapeutics Market Size by Type 10.2.1 Middle East & Africa Gout Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gout Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gout Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Gout Therapeutics Market Size by Application 10.3.1 Middle East & Africa Gout Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gout Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gout Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Gout Therapeutics Market Size by Country 10.4.1 Middle East & Africa Gout Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gout Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Takeda Pharmaceutical Company 11.1.1 Takeda Pharmaceutical Company Company Details 11.1.2 Takeda Pharmaceutical Company Business Overview 11.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction 11.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2016-2021) 11.1.5 Takeda Pharmaceutical Company Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Gout Therapeutics Introduction 11.2.4 Novartis Revenue in Gout Therapeutics Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Gout Therapeutics Introduction 11.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2016-2021) 11.3.5 AstraZeneca Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Gout Therapeutics Introduction 11.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2016-2021) 11.4.5 GlaxoSmithKline Recent Development 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Gout Therapeutics Introduction 11.5.4 Merck Revenue in Gout Therapeutics Business (2016-2021) 11.5.5 Merck Recent Development 11.6 Regeneron Pharmaceuticals 11.6.1 Regeneron Pharmaceuticals Company Details 11.6.2 Regeneron Pharmaceuticals Business Overview 11.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction 11.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2016-2021) 11.6.5 Regeneron Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of NSAIDs Table 3. Key Players of Corticosteroids Table 4. Key Players of Colchicine Table 5. Key Players of Urate-Lowering Agents Table 6. Global Gout Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Gout Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Gout Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Gout Therapeutics Market Share by Regions (2016-2021) Table 10. Global Gout Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Gout Therapeutics Market Share by Regions (2022-2027) Table 12. Gout Therapeutics Market Trends Table 13. Gout Therapeutics Market Drivers Table 14. Gout Therapeutics Market Challenges Table 15. Gout Therapeutics Market Restraints Table 16. Global Gout Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Gout Therapeutics Market Share by Players (2016-2021) Table 18. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Therapeutics as of 2020) Table 19. Ranking of Global Top Gout Therapeutics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Gout Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Gout Therapeutics Product Solution and Service Table 23. Date of Enter into Gout Therapeutics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Gout Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Gout Therapeutics Revenue Market Share by Type (2016-2021) Table 27. Global Gout Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Gout Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Gout Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Gout Therapeutics Revenue Market Share by Application (2016-2021) Table 31. Global Gout Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Gout Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Gout Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Gout Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Gout Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Gout Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Gout Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Gout Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Gout Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Gout Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Gout Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Gout Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Gout Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Gout Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Gout Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Gout Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Gout Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Gout Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 63. Takeda Pharmaceutical Company Company Details Table 64. Takeda Pharmaceutical Company Business Overview Table 65. Takeda Pharmaceutical Company Gout Therapeutics Product Table 66. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million) Table 67. Takeda Pharmaceutical Company Recent Development Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Gout Therapeutics Product Table 71. Novartis Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million) Table 72. Novartis Recent Development Table 73. AstraZeneca Company Details Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Gout Therapeutics Product Table 76. AstraZeneca Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million) Table 77. AstraZeneca Recent Development Table 78. GlaxoSmithKline Company Details Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Gout Therapeutics Product Table 81. GlaxoSmithKline Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million) Table 82. GlaxoSmithKline Recent Development Table 83. Merck Company Details Table 84. Merck Business Overview Table 85. Merck Gout Therapeutics Product Table 86. Merck Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million) Table 87. Merck Recent Development Table 88. Regeneron Pharmaceuticals Company Details Table 89. Regeneron Pharmaceuticals Business Overview Table 90. Regeneron Pharmaceuticals Gout Therapeutics Product Table 91. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2016-2021) & (US$ Million) Table 92. Regeneron Pharmaceuticals Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Gout Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. NSAIDs Features Figure 3. Corticosteroids Features Figure 4. Colchicine Features Figure 5. Urate-Lowering Agents Features Figure 6. Global Gout Therapeutics Market Share by Application: 2020 VS 2027 Figure 7. Acute Gout Case Studies Figure 8. Chronic Gout Case Studies Figure 9. Gout Therapeutics Report Years Considered Figure 10. Global Gout Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Gout Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Gout Therapeutics Market Share by Regions: 2020 VS 2027 Figure 13. Global Gout Therapeutics Market Share by Regions (2022-2027) Figure 14. Global Gout Therapeutics Market Share by Players in 2020 Figure 15. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Therapeutics as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2020 Figure 17. Global Gout Therapeutics Revenue Market Share by Type (2016-2021) Figure 18. Global Gout Therapeutics Revenue Market Share by Type (2022-2027) Figure 19. North America Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Gout Therapeutics Market Share by Type (2016-2027) Figure 21. North America Gout Therapeutics Market Share by Application (2016-2027) Figure 22. North America Gout Therapeutics Market Share by Country (2016-2027) Figure 23. United States Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Gout Therapeutics Market Share by Type (2016-2027) Figure 27. Europe Gout Therapeutics Market Share by Application (2016-2027) Figure 28. Europe Gout Therapeutics Market Share by Country (2016-2027) Figure 29. Germany Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Gout Therapeutics Market Share by Type (2016-2027) Figure 37. Asia-Pacific Gout Therapeutics Market Share by Application (2016-2027) Figure 38. Asia-Pacific Gout Therapeutics Market Share by Region (2016-2027) Figure 39. China Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Gout Therapeutics Market Share by Type (2016-2027) Figure 47. Latin America Gout Therapeutics Market Share by Application (2016-2027) Figure 48. Latin America Gout Therapeutics Market Share by Country (2016-2027) Figure 49. Mexico Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Gout Therapeutics Market Share by Type (2016-2027) Figure 53. Middle East & Africa Gout Therapeutics Market Share by Application (2016-2027) Figure 54. Middle East & Africa Gout Therapeutics Market Share by Country (2016-2027) Figure 55. Turkey Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Gout Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2016-2021) Figure 59. Novartis Revenue Growth Rate in Gout Therapeutics Business (2016-2021) Figure 60. AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2016-2021) Figure 61. GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Gout Therapeutics Business (2016-2021) Figure 63. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Takeda Pharmaceutical Company Novartis AstraZeneca GlaxoSmithKline Merck Regeneron Pharmaceuticals